OLE Identified as a Potential Alzheimer’s Therapy Targeting Microglia
The molecule N-oleoyl-Leucine (OLE), which is derived from the Alzheimer’s disease-associated gene PM20D1 , was shown to reduce amyloid pathology, improve cogni...
The molecule N-oleoyl-Leucine (OLE), which is derived from the Alzheimer’s disease-associated gene PM20D1 , was shown to reduce amyloid pathology, improve cognition, and promote neuroprotection. The post OLE Identified as a Potential Alzheimer’s Therapy Targeting Microglia appeared first on Inside Precision Medicine .